Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Raymond James HH Innovation Conference ...
View:
Post by MrMugsy on May 19, 2021 10:25am

Raymond James HH Innovation Conference ...

June 21 - 23, 2021

Raymond James Human Health Innovation Conference

Virtual Event

The conference will feature panel discussions with company executives and industry opinion leaders, with deep dives into themes, trends and changes in the healthcare industry.  Further information and details on Antibe’s presentation will be provided closer to the event.

Comment by woundedknee on May 19, 2021 10:29am
Never seen a conference yet that does the sp anygood. Just saying.
Comment by 123ABC on May 19, 2021 10:42am
Agreed, are we supposed to get excited by this? How many conference have been done this year and all the SP has done is drop?
Comment by baggerx99 on May 19, 2021 11:00am
One would believe industry goers would have heard of ATE by now and that there would be an overall interest. Bewildering for sure.
Comment by MrMugsy on May 19, 2021 12:34pm
Exactly - but - June 21 is the beginnning of summer madness (or sadness) depending on how some look at it.  We should be knee-deep into Phase three prep work and I hope they are sharing that news. We should also see what's taking us to NASDAQ in the fall by then - or soon after.  Looking for hints.  Maybe some OTENA partnerships.  Maybe some development partnerships.  ...more  
Comment by Layth1990 on May 19, 2021 12:25pm
in my experience , ATE presentations have no effect on the market. we already have done our research. i have no idea why There is no news for ph3 to clear the confusion!
Antibe Therapeutics Inc(Pre-Merger)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities